Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT04887818

Diltiazem Ointment With Lidocaine vs. Nifedipine Ointment With Lidocaine Ointment for Treatment of Chronic Anal Fissure

Assessment of Efficacy and Side Effects of Dlitiazem Ointment With Lidocaine vs. Diltiazem Ointment With Lidocaine for Treatment of Chronic Anal Fissure: Randomized Clinical Trial

Sponsor: University of Calgary

Conditions Fissure in Ano Rectal Bleed Rectal Diseases

Interventions 0.3% Nifedipine ointment with 1.5% lidocaine 2% Diltiazem ointment with 1.5% lidocaine

Updated 4 times since 2021 Last updated: May 12, 2021 Started: Jun 30, 2021 Primary completion: Dec 31, 2021 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04887818, this PHASE2/PHASE3 trial focuses on Fissure in Ano and Rectal Bleed and remains ongoing. Sponsored by University of Calgary, it has been updated 4 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
May 2023 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3

Status: Not Yet Recruiting → Unknown Status
Jun 2021 — May 2023 [monthly]

Not Yet Recruiting PHASE2_PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Calgary

Data source: University of Calgary

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Calgary, Canada